Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6880008 | 0.91 | TACR1 (0.41) | TACR1TACR3 | |
| SCHEMBL6879388 | 0.91 | TACR1 (0.53) | TACR1TACR3 | |
| SCHEMBL6871326 | 0.82 | TACR1 (0.51) | TACR1TACR3 | |
| SCHEMBL6877147 | 0.79 | TACR1 (0.49) | TACR1TACR3 | |
| SCHEMBL5803508 | 0.77 | TACR1 (0.51) | TACR1TACR3 | |
| SCHEMBL6880246 | 0.77 | CYP1A2 (0.40) | — | |
| SCHEMBL5800002 | 0.74 | TACR1 (0.53) | TACR1TACR3 | |
| SCHEMBL5800436 | 0.74 | TACR1 (0.52) | TACR1TACR3 | |
| SCHEMBL6880250 | 0.73 | CYP1A2 (0.41) | — | |
| SCHEMBL5799836 | 0.73 | TACR1 (0.65) | TACR1TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6787539-B2 | HAS ACTIVITY AS AN ANTAGONIST TO NEUROKININ 1 RECEPTORS; FOR THERAPY OF BENIGN PROSTATIC HYPERPLASIA (BPH) | HOFFMANN-LA ROCHE INC. | 2004-09-07 | — | — | US | disclosed |
| EP-1339698-A2 | PYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-09-03 | — | — | EP | disclosed |
| WO-2002042280-A2 | PYRIMIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2002-05-30 | — | — | WO | disclosed |